340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Report: Patient Groups Mum on High Drug Costs


 

Print Article

February 23, 2017—Big Pharma pours so much money into patient advocacy groups that the dough renders them mute on the drug price issue, according to a trenchant piece in USAToday.

“The National Patient Advocate Foundation receives 60 percent of its $2 million budget from the pharmaceutical industry, while the Colon Cancer Alliance gets 15 percent of its $1.2 million budget,” says the publication. “Several other groups get up to 20 percent of their revenue from drug companies.”

And surprise, surprise: NPAF and CCA have been harsh critics of the 340B drug discount program.

We’ve highlighted these conflicts of interest before but the alarm can’t be sounded often enough. While there are natural reasons drug companies and disease advocacy groups work closely, the enormous money spent gives the industry a convenient check on organized patient criticism on nearly any issue.

That investment has paid off handsomely in the drug pricing fight now gripping Washington. Currently, insurance companies and health providers are facing off against Big Pharma with hardly a patient in sight. Some patient groups put drug costs far down the list of priorities. “NPAF’s 2015 data on calls from about 14,000 cancer patients shows transportation was the top concern, followed by hospital and doctor co-pays, rent and mortgages and then prescription co-pays,” says the USAToday story.

Such is the power of the drug industry, even as it stumbles consistently in its effort to counter public ire over astronomical prices.

For a more realistic view of the situation, a new report in the Journal Cancer indicates some patients are cutting corners on their own treatment to avoid high drug bills.

340B helps needy patients avoid these impossible situations. Each day, thousands of Americans receive free or discounted medications and clinical services thanks to the program.

Recent Articles

  • HRSA Still Plans to Start Enforcing New 340B Regulation on April 1
  • Big Pharma Plays the Blame Game on Drug Prices
  • Report: Patient Groups Mum on High Drug Costs

Follow us on Twitter

340B HealthFollow

340B Health
340BHealth340B Health@340BHealth·
6h

Did you know more than half the members of the previous Congress urged @HHSGov to enforce the #340B statute and stop drug companies from denying program discounts? Learn more at http://www.stop340bcuts.org. #Protect340B

Reply on Twitter 1354064076251533314Retweet on Twitter 13540640762515333141Like on Twitter 13540640762515333141Twitter 1354064076251533314
340BHealth340B Health@340BHealth·
21h

#340B hospitals are helping lead the way in #COVID19 vaccine distribution. On today’s new episode of #340BInsight, we hear an inspiring vaccine distribution story from @StLukesHealth’s @therealrxmilner. Listen: http://bit.ly/3iSIHPt #TwitterRx

Reply on Twitter 1353838676988616704Retweet on Twitter 1353838676988616704Like on Twitter 13538386769886167043Twitter 1353838676988616704
340BHealth340B Health@340BHealth·
22h

It's #IVNurseDay! We extend our special thanks to the nurses at #340B hospitals who are providing this vital care to patients in need during #COVID19.

Reply on Twitter 1353812768084922368Retweet on Twitter 1353812768084922368Like on Twitter 13538127680849223682Twitter 1353812768084922368
Load More...

RSS 340B Informed

  • Senate Report Blasts Insulin Makers for High Prices
  • Government Opinion Paves the Way for Reversal of Drug Company Refusals to Provide 340B Discounts
  • Safety-Net Hospitals Launch the Beginning of the End of COVID-19

Copyright © 2021 · 340B Health